Dr. Tim Daniel Gearhart, DC Chiropractor - Sports Physician Medicare: Accepting Medicare Assignments Practice Location: 14 8th Ave Ne, Oelwein, IA 50662 Phone: 319-283-3824 Fax: 319-283-2647 |
Oelwein Chiropractic Clinic Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 14 8th Ave Ne, Oelwein, IA 50662 Phone: 319-283-3824 Fax: 319-283-2647 |
Dr. David Leonard Pratt, D.C. Chiropractor - Sports Physician Medicare: Medicare Enrolled Practice Location: 14 8th Ave Ne, Oelwein Chiropractic Clinic, Oelwein, IA 50662 Phone: 319-283-3824 Fax: 319-283-2647 |
Dr. Bradley J Brown, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 901 E Charles St, Oelwein, IA 50662 Phone: 319-283-1621 Fax: 319-283-3195 |
Karlee K Weidemann, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 14 8th Ave Ne, Oelwein, IA 50662 Phone: 319-283-3824 Fax: 319-283-2647 |
Brown Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 901 E Charles St, Oelwein, IA 50662 Phone: 319-283-1621 Fax: 319-283-3195 |
News Archive
A dramatic new study published in the most recent issue of Nature questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to diabetes.
Vaccines to protect against an avian influenza pandemic as well as seasonal flu may be mass produced more quickly and efficiently using technology described today (Sept. 2) by researchers at the University of Wisconsin-Madison in the journal Nature Communications.
Natus Medical Incorporated today announced that it has entered into a $50 million revolving credit facility with Wells Fargo Bank, National Association. The credit facility, which matures on April 30, 2012, amends and restates the Company's existing $25 million credit facility that was scheduled to mature on April 30, 2010.
In March, New Hampshire preschool teacher Gail O'Brien, who was unable to obtain health insurance through her employer, was diagnosed with an aggressive form of lymphoma. Her subsequent applications for health insurance were rejected because of her condition. With each round of chemotherapy costing $16,000, she delayed treatment because she knew her savings wouldn't last (Eric H. Holder and Kathleen Sebelius, 12/14).
To establish a molecular signature of this resistance in ovarian cancer, the authors developed preclinical tumor models of adaptive resistance to chronic anti-VEGF treatment.
› Verified 8 days ago